Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiora Pharmaceuticals (KPRX) Interest & Investment Income (2016 - 2025)

Kiora Pharmaceuticals (KPRX) has disclosed Interest & Investment Income for 11 consecutive years, with $201822.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest & Investment Income fell 18.89% year-over-year to $201822.0, compared with a TTM value of $1.1 million through Sep 2025, up 32.93%, and an annual FY2024 reading of $1.3 million, up 620.07% over the prior year.
  • Interest & Investment Income was $201822.0 for Q3 2025 at Kiora Pharmaceuticals, down from $225237.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $438860.0 in Q4 2024 and bottomed at $217.0 in Q1 2022.
  • Average Interest & Investment Income over 5 years is $145034.7, with a median of $127010.0 recorded in 2023.
  • The sharpest move saw Interest & Investment Income tumbled 98.64% in 2021, then soared 864.0% in 2024.
  • Year by year, Interest & Investment Income stood at $300.0 in 2021, then dropped by 27.67% to $217.0 in 2022, then skyrocketed by 20879.26% to $45525.0 in 2023, then skyrocketed by 864.0% to $438860.0 in 2024, then crashed by 54.01% to $201822.0 in 2025.
  • Business Quant data shows Interest & Investment Income for KPRX at $201822.0 in Q3 2025, $225237.0 in Q2 2025, and $276633.0 in Q1 2025.